NCT06056154View on ClinicalTrials.gov

Safety and Efficacy of the Hydrophobic Intraocular Lens Asqelio Monofocal With Biaspheric Design

Enrolling by invitationOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

January 17, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

July 31, 2025

Conditions
CataractPseudophakia
Interventions
DEVICE

LIO ASQELIO TM monofocal QLIO130C

Intraocular lens (IOL) implant. All patients will have been treated as per standard clinical practice.

Trial Locations (1)

46026

Oftalmología Vistahermosa SL, Alicante

All Listed Sponsors
lead

AST Products, Inc.

INDUSTRY